17-alpha-hydroxyprogesterone

17-al·pha-hy·drox·y·pro·ges·ter·one

(-ăl′fə-hī-drŏk′sē-prō-jĕs′tə-rōn′)
n.
A compound produced by the adrenal glands and often used therapeutically as a progestogen when such a steroid is needed for parenteral administration.
References in periodicals archive ?
Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
For women who had a prior preterm birth, cervical cerclage was offered, as well as vaginal progesterone if the patient was not already on 17-alpha-hydroxyprogesterone caproate.
What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth.
Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate.
The Food and Drug Administration has approved 17-alpha-hydroxyprogesterone caproate, a progesterone injection also known as 17P, for the prevention of recurrent preterm birth in women with singleton pregnancies.
17-alpha-hydroxyprogesterone. This is a synthetic progesterone given in doses from 25 mg to 1 000 mg by intramuscular injection in schedules from weekly to thrice weekly.
He pinpointed Takeover Target because of his ban for failing a test for 17-alpha-hydroxyprogesterone hexanoate, or HPC, a steroid that can build muscle.
The new treatment, weekly shots of a hormone called 17-alpha-hydroxyprogesterone caproate, or 17P, were started at sixteen to eighteen weeks of pregnancy and stopped at thirty-six weeks.
In this case, the FDA had approved a compounded therapy 17-alpha-hydroxyprogesterone caproate (17P) to prevent preterm birth.
This randomized trial of 69 women who experienced preterm premature rupture of membranes (PPROM) at 20 to 30 weeks' gestation found no difference in the length of gestation between women given 250 mg of 17-alpha-hydroxyprogesterone (17P) or placebo weekly.
The case comes after last year's King's Stand winner and Golden Jubilee third, Takeover Target, was controversially denied a run in the Hong Kong Sprint after testing positive for a steroid (17-alpha-hydroxyprogesterone hexanoate) that is a legal intramuscular treatment in Hong Kong but cannot be in a horse's system when racing.
CHICAGO -- The effect of 17-alpha-hydroxyprogesterone caproate on preterm birth varies depending on the presence or absence of cerclage in high-risk women, according to a planned secondary analysis of the Vaginal Ultrasound Cerclage Trial.